February 3, 2021 – Sysmex Corporation (Kobe, Japan) and Siemens Healthcare Diagnostics Inc. announced that, on February 2, 2021, the two companies agreed to extend their long-standing alliance on global supply, distribution, and sales and service for hemostasis products through at least 2023.
The extension of the agreement will continue to allow Sysmex and Siemens Healthineers to mutually supply hemostasis systems and reagents, respectively, on a global basis.
The renewed agreement contains a partial review of the list of products and territories for mutual supply.
Sysmex hopes that it will reinforce the sales of Sysmex’s CN-Series automated blood coagulation analyzer and allow the two companies to maintain the proven cooperative framework to offer ample solutions for hemostasis testing to customers around the world.
Additionally, Sysmex and Siemens Healthineers will continue to harness each other’s strengths to expand the hemostasis business, with a view toward contributing to the standardization and enhanced quality of hemostasis testing.